| Literature DB >> 35687713 |
Shaymaa Abdalwahed Abdulameer1, Mohanad Naji Sahib1, Syed Azhar Syed Sulaiman2.
Abstract
INTRODUCTION: Osteoporosis and diabetes are highly prevalent diseases. In addition, there is increasing evidence that diabetes is a common risk factor for decreasing bone mineral density and developing osteoporosis and fractures. Data on bone abnormalities in T2DM patients appear to be contradictory and complex, and the exact underlying mechanism is still unclear. Hence, the aims of this study were to assess cognitive perspective of osteoporosis among type 2 diabetes mellitus.Entities:
Keywords: osteoporosis; self efficacy; type 2 diabetes mellitus
Mesh:
Substances:
Year: 2022 PMID: 35687713 PMCID: PMC9258993 DOI: 10.1002/edm2.354
Source DB: PubMed Journal: Endocrinol Diabetes Metab ISSN: 2398-9238
Relationships between osteoporosis self‐efficacy levels and patients' demographic characteristics (N = 450)
| Variable | Frequency (Per cent%) | OSES‐M levels |
| OSES‐M scores Mean ± SD |
| |
|---|---|---|---|---|---|---|
| Low OSES‐M level | High OSES‐M level | |||||
| 321 (71.3%) | 129 (28.7%) | |||||
| Age groups | ||||||
| <45 years | 11 (2.40%) | 10 (90.90%) | 1 (9.10%) | .114 | 638.64 | .529 |
| 45–54 years | 78 (17.30%) | 59 (75.60%) | 19 (24.40%) | 731.26 | ||
| 55–64 years | 166 (36.90%) | 123 (74.10%) | 43 (25.90%) | 732.70 | ||
| ≥65 years | 195 (43.30%) | 129 (66.20%) | 66 (33.80%) | 735.26 | ||
| Gender | ||||||
| Male | 231 (51.30%) | 158 (68.40%) | 73 (31.60%) | .157 | 752.93 | .024a |
| Female | 219 (48.70%) | 163 (74.40%) | 56 (25.60%) | 708.41 | ||
| Race | ||||||
| Malay | 127 (28.20%) | 91 (71.70%) | 36 (28.30%) | .480 | 747.68 | .011a |
| Chinese | 204 (45.30%) | 150 (73.50%) | 54 (26.50%) | 699.88 | ||
| Indian | 119 (26.40%) | 80 (67.20%) | 39 (32.80%) | 767.54 | ||
| Educational levels | ||||||
| <12 years | 285 (63.30%) | 217 (76.10%) | 68 (23.90%) | .003 b | 693.25 ± 208.44 | <.001c |
| ≥12 years | 165 (36.70%) | 104 (63%) | 61 (37%) | 796.92 ± 196.11 | ||
| Marital Status | ||||||
| Single | 70 (15.60%) | 55 (78.60%) | 15 (21.40%) | .145 | 697.71 | .146 |
| Not single | 380 (84.40%) | 266 (70%) | 114 (30%) | 737.44 ± 209.71 | ||
| Monthly income | ||||||
| Less than RM 2000 | 330 (73.30%) | 244 (73.90%) | 86 (26.10%) | .043a | 720.18 ± 201.98 | .063 |
| More than RM 2000 | 120 (26.70%) | 77 (64.20%) | 43 (35.80%) | 761.73 ± 228.16 | ||
| Menopausal status ( | ||||||
| Premenopausal | 25 (11.40%) | 21 (84%) | 4 (16%) | .244 | 659.12 | .194 |
| Postmenopausal | 194 (88.60%) | 142 (73.20%) | 52 (26.80%) | 714.76 | ||
| Employment status | ||||||
| Working | 192 (42.70%) | 133 (69.30%) | 59 (30.70%) | .404 | 744.25 ± 223.19 | .258 |
| Not working | 258 (57.30%) | 188 (72.90%) | 70 (27.10%) | 721.60 ± 199.21 | ||
| Living place | ||||||
| Rural | 90 (20%) | 57 (63.30%) | 33 (36.70%) | .061 | 765.64 | .082 |
| Urban | 360 (80%) | 264 (73.30%) | 96 (26.70%) | 722.67 | ||
| Family history of osteoporosis | ||||||
| No | 392 (87.10%) | 289 (73.70%) | 103(26.30%) | .004b | 723.99 | .056 |
| Yes | 58 (12.90%) | 32 (55.20%) | 26 (44.80%) | 780.41 | ||
| Family history of fracture | ||||||
| No | 359(79.80%) | 265 (73.80%) | 94 (26.20%) | .021a | 723.71 | .129 |
| Yes | 91 (20.20%) | 56 (61.50%) | 35 (38.50%) | 761.07 | ||
| Smoking habit | ||||||
| Not smoking | 318 (70.70%) | 232 (73%) | 86 (27%) | .237 | 721.03 | .108 |
| Smoking | 132 (29.30%) | 89 (67.40%) | 43 (32.60%) | 755.92 | ||
| Alcohol habit | ||||||
| Non alcoholic | 356 (79.10%) | 268 (75.30%) | 88 (24.70%) | <.001c | 714.63 | .001b |
| Alcoholic | 94 (20.90%) | 53 (56.40%) | 41 (43.60%) | 794.24 | ||
| BMI (Kg/m2) | ||||||
| Non‐obese (BMI ≤23 kg/m2) | 98 (21.80%) | 71 (72.40%) | 27 (27.60%) | .782 | 745.41 | .451 |
| Obese(BMI >23 kg/m2) | 352(78.20%) | 250 (71%) | 102 (29%) | 727.32 | ||
Abbreviations: BMI, body mass index; SD, standard deviation.
Association, chi‐square test, a p < .05, b p < .01, c p < .001.
Difference.
Relationships between OSES‐M levels and diabetes‐related variables (N = 450)
| Variable | Frequency (Per cent%) | Osteoporosis self‐efficacy level |
| OSES‐M scores Mean ± SD |
| |
|---|---|---|---|---|---|---|
| Low OSES level | High OSES level | |||||
| 321 (71.3%) | 129 (28.7%) | |||||
| Diabetes duration (years) | ||||||
| <5 | 175 (38.90) | 120 (68.60%) | 55 (31.40%) | .366 | 745.80 | .114 |
| 5–9 | 125 (27.80) | 89 (71.20%) | 36 (28.80%) | 737.26 | ||
| 10–14 | 89 (19.80) | 70 (78.70%) | 19 (21.30%) | 683.33 | ||
| ≥15 | 61 (13.60) | 42 (68.90%) | 19 (31.10%) | 747.21 | ||
| Therapy type | ||||||
| Mono therapy | 115 (25.60) | 84 (73%) | 31 (27%) | .638 | 699.15 | .057 |
| Combined therapy | 335 (74.40) | 237 (70.70%) | 98 (29.30%) | 742.29 | ||
| Insulin use | ||||||
| With insulin | 67 (14.90) | 40 (59.70%) | 27 (40.30%) | .022a | 800.55 | .003b |
| Without insulin | 383 (85.10) | 281 (73.40%) | 102 (26.60%) | 719.14 | ||
| Diabetic complication (DC) | ||||||
| Positive (with DC) | 330 (73.30) | 234 (70.90%) | 96 (29.10%) | .741 | 734.21 | .622 |
| Negative (without DC) | 120 (26.70) | 87 (72.50%) | 33 (27.50%) | 723.16 | ||
| Co‐morbidities | ||||||
| Positive (with Co‐morbidities) | 426 (94.70) | 305 (71.60%) | 121(28.40%) | .603 | 729.35 | .416 |
| Negative (without Co‐morbidities) | 24 (5.30) | 16 (66.70%) | 8 (33.30%) | 765.21 | ||
| Glycaemic control (%) | ||||||
| Good HbA1c(<6.5) | 107 (23.80) | 77 (72%) | 30 (28%) | .869 | 752.35 | .234 |
| Poor HbA1c (≥6.5) | 343 (76.20) | 244 (71.10%) | 99 (28.90%) | 724.69 | ||
Abbreviation: SD, standard deviation.
Association, chi‐square test, a p < .05, b p < .01.
Difference.
Independent t‐test.
ANOVA.